Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Autoimmune Diseases × human papillomavirus vaccine, L1 type 16, 18 × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Papillomavirus Infections 38 Uterine Cervical Neoplasms 19 Uterine Cervical Dysplasia 4 Virus Diseases 3 Human Papillomavirus-Related Cervical Carcinoma 2 Warts 1 Precancerous Conditions 1 Infections 1 Human Papillomavirus Infection Leading to Cervical Cancer 1 Hepatitis B 1 Condylomata Acuminata 1 Autoimmune Diseases 1 Acquired Immunodeficiency Syndrome 1 Abortion, Spontaneous 1

Interventions

telitacicept 3 fludarabine 3 Prednisone 3 Data Collection 3 Cyclophosphamide 3 Specimen Handling 2 Nivolumab 2 Blood Specimen Collection 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 human papillomavirus vaccine, L1 type 16, 18 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 apremilast 1 Watchful Waiting 1 Vitamin D 1 Valsartan 1 Surveys and Questionnaires 1 Standard of Care 1 Pyridostigmine Bromide 1 Practice Guidelines as Topic 1 Population Groups 1 Plasma Exchange 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Music Therapy 1 Methods 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01498627 2015-04-06

PGRx

GlaxoSmithKline

Autoimmune Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡